Stay updated on Monalizumab Plus Cetuximab Clinical Trial
Sign up to get notified when there's something new on the Monalizumab Plus Cetuximab Clinical Trial page.

Latest updates to the Monalizumab Plus Cetuximab Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed descriptions of a Phase 3 study on monalizumab and cetuximab for treating recurrent or metastatic squamous cell carcinoma of the head and neck, while retaining key identifiers and study structure information.SummaryDifference11%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 24, 2025.SummaryDifference0.2%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version release, moving from v2.14.2 to v2.14.3, and the last update date has changed from February 24, 2025, to March 25, 2025.SummaryDifference0.2%
- Check73 days agoChange DetectedThe webpage has updated its date references to include February 2025, while removing older dates from January 2025. Additionally, a notice regarding service performance and contact information for assistance has been removed.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.8%
Stay in the know with updates to Monalizumab Plus Cetuximab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Monalizumab Plus Cetuximab Clinical Trial page.